Page URL:

Breast cancer gene raises lung cancer risk in smokers

9 June 2014
Appeared in BioNews 757

Smokers are more likely to develop lung cancer if they carry a defective version of a gene associated with breast cancer, a study has found.

Mutations in the BRCA2 gene have long been linked to increased risk of developing breast,ovarian and prostate cancers. Now, researchers have found that that a specific variant of the gene also increases the risk of lung cancer, particularly in smokers. Lifetime risk for developing lung cancer for smokers, normally at around 13 percent, rises to 25 percent for those that possess the defective gene.

This means that smokers with this mutant BRCA2 have a one in four chance of developing cancer – almost double the risk of those who don't smoke. The mutant gene is present in about two percent of the population, so given that there are 10 million adult smokers in the UK, the researchers estimate that up to 200,000 people could be affected.

'Our study showed that mutations to [BRCA2] have a very large effect on lung cancer risk in the context of smoking', said Professor Richard Houlston from the Institute of Cancer Research in the UK, one of the lead researchers. 'Some smokers with BRCA2 mutations are at an enormous risk of lung cancer – somewhere in the region of 25 percent over their lifetime', he added.

In the study, published in Nature Genetics, the researchers compared the DNA of over 11,000 lung cancer patients with that of almost 16,000 healthy controls, all of European ancestry, and looked for differences between the two groups. They found that the variant of BRCA2 known as c.9976T was more common in the patients with lung cancer than without, particularly in squamous cell lung cancer, the most common lung cancer type.

It is thought that mutant BRCA2 can no longer properly repair damaged DNA caused by smoking. 'In the context of smoking there is such an enormous amount of DNA damage that any loss of DNA repair is going to be an issue', Professor Houlston told BBC News.

Specific drugs for breast or ovarian cancer patients with BRCA2 mutations are in development and have already shown promising results in clinical trials. This raises the possibility that these drugs, called PARP inhibitors, may also work in lung cancer patients with mutant BRCA2. However, this is only speculative, as whether the drugs will actually work against lung cancer is not known.

This study confirms that there is an inherited genetic susceptibility to lung cancer. Professor Paul Workman, from the Institute of Cancer Research, said: 'All smokers are taking a considerable risk with their health, regardless of their genetic profile, but the odds are stacked even more heavily against those with this genetic defect who smoke'.

Breast cancer gene now linked to lung cancer among smokers
The Independent |  1 June 2014
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer
Nature Genetics |  1 June 2014
Smokers with gene defect have one in four chance of developing lung cancer
Institute of Cancer Research (press release) |  1 June 2014
Smoking and breast cancer gene combine 'to raise risk'
BBC News |  1 June 2014
28 September 2015 - by Antony Starza-Allen 
Health and genetic data from the UK Biobank has revealed new genetic associations between smoking and lung cancer, including five areas of DNA for the first time associated with heavy smoking.
15 September 2014 - by Antony Starza-Allen 
Scientists have shown that minimal genetic changes can be detected in vapour containing cells engineered to replicate early stage lung cancer....
4 August 2014 - by Daryl Ramai 
Scientists at the Children's Nutrition Research Center, USA have shown that epigenetic changes alone could cause cancer....
30 June 2014 - by Dr Nicoletta Charolidi 
A simple blood test that can predict the likelihood of developing non-inherited breast cancer could be developed, following research into the epigenetics of the disease...
19 May 2014 - by Antony Starza-Allen 
British pharmaceutical company AstraZeneca has presented trial data from an experimental lung cancer drug...
7 April 2014 - by Dr Kimberley Bryon-Dodd 
Smoking before puberty may lead to men fathering fatter sons, suggesting that lifestyle factors can have adverse impacts on the next generation, a study has found...
2 December 2013 - by Dr Charlotte Warren-Gash 
Women from families with a history of carrying the cancer risk gene BRCA2, but who test negative for it, may be at higher risk of breast cancer than previously thought...
4 November 2013 - by Dr Sarah Spain 
Two recent studies have shown how treatments for lung cancer can be tailored to a tumour's genetic make-up, which may ultimately improve existing treatments or even help to identify new ones...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.